相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Novel Mode of Intervention with Serine Protease Activity TARGETING ZYMOGEN ACTIVATION
Grant E. Blouse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The myofibroblast and its tumours
B. Eyden et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites
Saurabh Aggarwal et al.
BIOCHEMISTRY (2008)
Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts
Elinborg Ostermann et al.
CLINICAL CANCER RESEARCH (2008)
Fibroblast activation protein and chronic liver disease
Xin Maggie Wang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A. Havre et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis
Kazuhiro Noma et al.
GASTROENTEROLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J. Cohen et al.
PANCREAS (2008)
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions
Mariusz Adam Goscinski et al.
ULTRASTRUCTURAL PATHOLOGY (2008)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Requirement for Rac1 in a K-ras-induced lung cancer in the mouse
Joseph L. Kissil et al.
CANCER RESEARCH (2007)
Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype
Arnaud Besson et al.
GENES & DEVELOPMENT (2007)
Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization
Sarah A. Meadows et al.
BIOCHEMISTRY (2007)
Clinical implications of fibroblast activation protein in patients with colon cancer
Leonard R. Henry et al.
CLINICAL CANCER RESEARCH (2007)
Effect of fibroblast activation protein and α2-antiplasmin cleaving enzyme on collagen types I, III, and IV
Victoria J. Christiansen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp-2-dependent and -independent mechanisms
Patrick Bryant et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity
CY Edosada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly2-Pro1-cleaving specificity
CY Edosada et al.
FEBS LETTERS (2006)
Fibroblast activation protein:: a serine protease expressed at the remodeling interface in idiopathic pulmonary flbrosis
PS Acharya et al.
HUMAN PATHOLOGY (2006)
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
J Grimm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7
Y Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by vildagliptin ((2S)-{[3-hydroxyadamantan-1-yl) amino]acetyl}-pyrrolidine-2-carbonitrile)
I Brandt et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation
L Moro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α
K Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
DA Tuveson et al.
CANCER CELL (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
PT-100, a small molecule dipeptidyl peptidase inhibitorg has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism
S Adams et al.
CANCER RESEARCH (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma
T Armstrong et al.
CLINICAL CANCER RESEARCH (2004)
Endothelial-pericyte interactions in angiogenesis
H Gerhardt et al.
CELL AND TISSUE RESEARCH (2003)
1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine:: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
EB Villhauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Fibroblast activation protein: Differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors
MA Huber et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Stromal antigen targeting by a humanised monoclonal antibody:: An early phase II trial of sibrotuzamab in patients with metastatic colorectal cancer
RD Hofheinz et al.
ONKOLOGIE (2003)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson et al.
NATURE (2001)
Targeted disruption of mouse fibroblast activation protein
J Niedermeyer et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)